shutterstock_1214634313_piotr_swat
Piotr Swat / Shutterstock.com
25 October 2019AmericasSarah Morgan

AbbVie and AstraZeneca settle cancer drug patent suits

AbbVie and AstraZeneca reached a settlement over patent suits involving their rival cancer drugs earlier this week, after nearly two years of litigation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
19 October 2021   AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.

More on this story

Generics
19 October 2021   AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.

More on this story

Generics
19 October 2021   AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.